Concepedia

Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India

Anantbhushan Ranade, Deepak Joshi, Girish K. Phadke, Prof Prajakta Patil, R.B. Kasbekar, T.G. Apte, R. R. Dasare, S.D. Mengde, Purvish M. Parikh, Gouri Shankar Bhattacharyya,

Annals of Oncology · 2013 · 57 citations · 4 references

DOIFull text

Open access

Concepts

References

4

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al. · American Journal of Clinical Oncology · 1982 · 11.6K citations

, , +8

Hypersensitivity reactions from taxol.

R B Weiss, Ross C. Donehower, Peter H. Wiernik et al. · Journal of Clinical Oncology · 1990 · 1.2K citations

, , +9

Phase I clinical and pharmacokinetic study of taxol.

Peter H. Wiernik, Edward L. Schwartz, J Strauman et al. · PubMed · 1987 · 454 citations

, , +14

A novel nanopolymer based tumor targeted delivery system for paclitaxel

Anu Singh, Manu Jaggi, Dhiraj Khattar et al. · Journal of Clinical Oncology · 2008 · 10 citations

, , +17